Atossa Therapeutics
ATOS
#9180
Rank
โ‚ฌ93.9 M
Marketcap
0,73ย โ‚ฌ
Share price
5.11%
Change (1 day)
-39.23%
Change (1 year)

Earnings for Atossa Therapeutics (ATOS)

Earnings in 2025 (TTM): -โ‚ฌ25.95 Million

According to Atossa Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -โ‚ฌ21.82 Million, an increase over its 2023 earnings that were of -โ‚ฌ25.74 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Atossa Therapeutics from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ25.95 Million18.95%
2024 -โ‚ฌ21.82 Million-15.25%
2023 -โ‚ฌ25.74 Million11.62%
2022 -โ‚ฌ23.06 Million30.84%
2021 -โ‚ฌ17.63 Million15.58%
2020 -โ‚ฌ15.25 Million3.41%
2019 -โ‚ฌ14.75 Million51.16%
2018 -โ‚ฌ9.76 Million40.41%
2017 -โ‚ฌ6.95 Million27.54%
2016 -โ‚ฌ5.45 Million-47.49%
2015 -โ‚ฌ10.38 Million-17.25%
2014 -โ‚ฌ12.54 Million35.91%
2013 -โ‚ฌ9.23 Million112.3%
2012 -โ‚ฌ4.35 Million46.53%
2011 -โ‚ฌ2.97 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ27.70 B-112,907.30%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ1.14 B-4,742.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ1.10 B-4,581.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-โ‚ฌ6.71 Million-72.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
โ‚ฌ35.64 M-245.14%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-โ‚ฌ93.41 Million 280.29%๐Ÿ‡บ๐Ÿ‡ธ USA